A randomised, open-label, multicentre, efficacy and safety study examining the effects on viral kinetics of all-trans retinoic acid (Tretinoin) (VESANOID®) in combination with pegylated interferon alpha-2a (PEGASYS®) and ribavirin (COPEGUS®) therapy in patients with genotype 1-chronic hepatitis C and non-response to a previous course of peg-interferon alpha/ribavirin combination (ATRACTION)
Keyword(s):
2019 ◽
Vol 15
(6)
◽
pp. 595-600
◽
Keyword(s):
2015 ◽
Vol 54
(20)
◽
pp. 2551-2560
◽
Keyword(s):